Scientific Session
Rheumatoid arthritis (RA)
Deepak Rao, MD, PhD
Brigham and Women's Hospital
Boston, MA, United States
Disclosure(s): AstraZeneca: Consultant (Ongoing); Bristol-Myers Squibb: Consultant (Ongoing), Grant/Research Support (Ongoing); GlaxoSmithKlein(GSK): Consultant (Terminated, April 6, 2023); Hifibio: Consultant (Ongoing); Janssen: Grant/Research Support (Ongoing); Merck: Grant/Research Support (Ongoing); Scipher Medicine: Consultant (Ongoing)